Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- Check6 days agoChange DetectedAdded related topics: Multiple Myeloma and MedlinePlus Genetics as minor metadata updates; there is no change to the core trial details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedThe changes are minor metadata updates: a new Revision: v3.4.2 banner and the removal of older topics/links such as Revision: v3.4.1, Multiple myeloma, related topics, and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA government funding notice was added at the top of the page. Related topics (Multiple Myeloma, MedlinePlus Genetics) were added, and the revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedShow glossary was added and metadata labels updated to include Last Update Submitted that Met QC Criteria and Revision: v3.4.0. The term 'Multiple Myeloma' and several related topics (e.g., MedlinePlus Genetics) were removed from the related topics, reflecting a metadata adjustment rather than substantive study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check35 days agoChange Detected- Related topics updated: 'Multiple myeloma' is now listed and 'MedlinePlus Genetics' is added under related topics.SummaryDifference0.1%

- Check42 days agoChange DetectedThe top revision badge updated from v3.3.3 to v3.3.4, indicating a minor update.SummaryDifference0.0%

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.